# Baricitinib for Respiratory Injury in Patients With Intracerebral Hemorrhage

> **NCT06737705** · PHASE2 · COMPLETED · sponsor: **De-zhi Kang** · enrollment: 110 (actual)

## Conditions studied

- Intracerebral Hemorrhage
- Acute Lung Injury(ALI)

## Interventions

- **DRUG:** Baritinib

## Key facts

- **NCT ID:** NCT06737705
- **Lead sponsor:** De-zhi Kang
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-01-01
- **Primary completion:** 2025-08-18
- **Final completion:** 2025-08-18
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2025-08-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06737705

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06737705, "Baricitinib for Respiratory Injury in Patients With Intracerebral Hemorrhage". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06737705. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*